A detailed history of Thrive Capital Management, LLC transactions in Insulet Corp stock. As of the latest transaction made, Thrive Capital Management, LLC holds 6,895 shares of PODD stock, worth $2.29 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
6,895
Previous 5,912 16.63%
Holding current value
$2.29 Million
Previous $1.86 Million 14.59%
% of portfolio
0.55%
Previous 0.58%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 28, 2025

BUY
$277.3 - $352.82 $272,585 - $346,822
983 Added 16.63%
6,895 $2.13 Million
Q2 2025

Aug 08, 2025

BUY
$238.57 - $327.47 $877,221 - $1.2 Million
3,677 Added 164.52%
5,912 $1.86 Million
Q1 2025

Apr 30, 2025

BUY
$237.06 - $288.29 $529,829 - $644,328
2,235 New
2,235 $586,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $23.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Thrive Capital Management, LLC Portfolio

Follow Thrive Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrive Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thrive Capital Management, LLC with notifications on news.